GlassScriptPhysician profile
Frank Martin Casey
NPI 1174645329
$8,933.27
in general payments reported to CMS, 2019-2025
49 companies · $1,154 in 2025
The $1,154 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,371 · 2020: $447 · 2021: $1,613 · 2022: $1,165 · 2023: $1,781 · 2024: $1,401 · 2025: $1,154.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,336 · Education: $1.10.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,335.93 |
| Education | $1.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,284.95 | 2021-2025 | Interstim, Altaviva |
| Abbvie INC. | $792.78 | 2019-2025 | Botox, Lupron Depot |
| Myriad Genetic Laboratories, INC. | $785.13 | 2022-2025 | Prolaris, Myrisk |
| Boston Scientific Corporation | $777.89 | 2019-2025 | Rezum Generator, Coyote Es, Ranger |
| Cook Medical LLC | $733.55 | 2019-2023 | Fiber Dust |
| Astellas Pharma US INC | $577.99 | 2019-2024 | Xtandi |
| Pfizer INC. | $463.87 | 2019-2025 | |
| Coloplast Corp | $350.34 | 2021-2025 | Porges Coloplast |
| Endo Pharmaceuticals INC. | $257.97 | 2019-2024 | Xiaflex, Aveed |
| Ambu INC. | $194.06 | 2021-2024 | |
| Janssen Biotech, INC. | $186.30 | 2019-2025 | Erleada |
| Accord Healthcare, INC. | $170.52 | 2022 | |
| Blue Earth Diagnostics | $170.23 | 2019-2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $167.28 | 2020-2024 | |
| Dendreon Pharmaceuticals LLC | $162.48 | 2019-2025 | Provenge |
Show all 49 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $152.92 | 2025 | Barrigel |
| Antares Pharma, INC. | $129.57 | 2019-2022 | |
| Urogen Pharma, INC. | $126.92 | 2020-2025 | Jelmyto |
| Merck Sharp & Dohme LLC | $116.99 | 2022-2025 | Lynparza, Keytruda |
| Astrazeneca Pharmaceuticals LP | $114.71 | 2021-2025 | Lynparza |
| Myovant Sciences INC. | $109.43 | 2021-2022 | |
| Amgen INC. | $106.26 | 2019-2021 | |
| Sumitomo Pharma America, INC. | $104.30 | 2023-2025 | Orgovyx, Gemtesa |
| Verity Pharmaceuticals INC. | $77.55 | 2023-2024 | Trelstar |
| Medtronic USA, INC. | $73.22 | 2019-2020 | |
| Travere Therapeutics, INC. | $63.95 | 2019-2025 | Thiola |
| Novartis Pharmaceuticals Corporation | $57.88 | 2019-2025 | |
| Allergan, INC. | $51.29 | 2019-2021 | |
| Endo USA, INC. | $42.41 | 2025 | Xiaflex, Aveed |
| Karl Storz Endoscopy-America | $41.42 | 2025 | |
| Tolmar, INC. | $41.03 | 2025 | Eligard, Jatenzo |
| Ferring Pharmaceuticals INC. | $38.97 | 2019 | |
| Clarus Therapeutics INC. | $38.86 | 2021 | |
| Rochester Medical Corporation | $38.45 | 2021 | |
| Agiliti Surgical, INC. | $38.44 | 2024-2025 | Sonablate Hifu, Koelis Trinity Fusion Biopsy System, Soltive Superpulsed Laser |
| Tolmar Pharmaceuticals, INC. | $35.88 | 2020-2021 | |
| Halozyme INC | $34.04 | 2023 | |
| 180 Medical, INC. | $31.16 | 2020-2021 | |
| C. R. Bard, INC. & Subsidiaries | $30.44 | 2022 | |
| Immunitybio, INC. | $22.62 | 2025 | |
| Dentsply Ih Ab | $20.51 | 2025 | Lofric |
| Axonics, INC. | $17.69 | 2020 | |
| Urovant Sciences INC | $17.36 | 2022 | |
| Calyxo, INC. | $15.90 | 2024 | Cvac Aspiration System |
| Therapeuticsmd, INC. | $15.78 | 2019 | |
| Olympus America INC. | $15.54 | 2025 | Itind System |
| Angiodynamics, INC. | $13.09 | 2023 | Nanoknife |
| Mission Pharmacal Company | $12.05 | 2019 | |
| Acerus Pharmaceuticals Corporation | $11.30 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Frank Casey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.